Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

SSTR2 as an Independent Prognostic Indicator for Neuroendocrine Tumors

Introduction:Somatostatin receptor antagonists are used in radionuclide-targeted therapy for neuroendocrine tumors, while the detection...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

INI-1: A Multi-Tumor Diagnostic and Differentiation Indicator

Introduction:INI-1 (Integrase interactor-1) is a core subunit of the SWI/SNF chromatin remodeling complex, expressed in all normal cell...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Emergency Consultation During Surgery

Introduction:Can you imagine that halfway through a patient's surgery, an 'emergency consultation' might be needed? Perhaps, for ordina...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

New Antibody // SMARCA4/Brg1—An Independent Predictor of Multi-Tumor Progression and Treatment Efficacy

Preface:The Brg1 (SMARCA4) gene plays a significant role in the development and progression of approximately 20% of human tumors, but i...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Week 34 of “Mai Mai” Pathology Reading Notes | Immunohistochemical Markers for the Diagnosis of Muscle Tissue Tumors

Introduction:Muscle tissue tumors are one of the more common soft tissue tumors in clinical practice. Thanks to advances in diagnostic ...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Pathology Weekly Reading Notes Issue 37: Immunohistochemical Markers for Diagnosing Central Nervous System Tumors and Meningiomas

Introduction:Central nervous system tumors refer to a group of benign and malignant diseases originating from tissues or structures wit...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Pepsinogen I and H+/K+ ATPase β: Specific Markers for Gastric Fundic Gland Adenocarcinoma

Introduction:Gastric adenocarcinoma of fundic gland type (GA-FG), first included and introduced in the 5th edition of the WHO Classific...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Tumor Talk: Is It Really Harmless If It’s Called a Tumor?

Introduction:In previous episodes of 'Tumor Talk', we discussed tumor formation, how to distinguish between benign and malignant tumors...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Twenty-ninth Issue of “Mai Mai” Pathology Weekly Reading Notes | Overview of Immunohistochemical Markers for Lymphoid Neoplasms Diagnosis (Part Five)

Preface:Hodgkin lymphoma (HL) is a common type of lymphoma, and its diagnosis is primarily based on pathological histological examinati...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Application of Immunohistochemistry in the Classification of Salivary Gland Tumors (Part 2)

Introduction:In the previous article, we mentioned that this series will discuss the differential diagnosis of salivary gland tumors ba...
Continue reading
  • «
  • ‹
  • 11
  • 12
  • 13
  • 14
  • 15
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar